Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo® for Eligible Patients With Multi-Drug Resistant HIV-1
26 oct. 2021 02h00 HE
|
Theratechnologies
MONTREAL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of...
Theratechnologies annoncera ses résultats financiers du troisième trimestre de l’exercice 2021
29 sept. 2021 08h30 HE
|
Theratechnologies
MONTRÉAL, 29 sept. 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) (NASDAQ:THTX), une compagnie biopharmaceutique se spécialisant dans la commercialisation et le...
Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021
29 sept. 2021 08h30 HE
|
Theratechnologies
MONTREAL, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of...
Theratechnologies Announces Financial Results for Fiscal Year 2017
07 févr. 2018 07h30 HE
|
Theratechnologies
MONTREAL, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced its financial results for the year ended November 30, 2017. Fiscal Year 2017...
Theratechnologies annonce ses résultats financiers pour l’exercice 2017
07 févr. 2018 07h30 HE
|
Theratechnologies
MONTRÉAL, 07 févr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX:TH) a annoncé aujourd’hui ses résultats financiers pour l’exercice clos le 30 novembre 2017....